MALDI-ToF Mass Spectrometry
- VeriStrat® Test
- ImmunoStrat® Protein Signatures
- Lung Cancer Risk of Recurrence Test
- Biological Pathway Protein Score
- Custom Signature Discovery
Working alongside our biopharmaceutical partners, we employ personalized and integrated approaches to uncover new solutions to diagnostic challenges with industry-leading expertise in blood-based testing.
In addition to traditional statistical methods used for known biomarker targets, we employ a unique approach to discover innovative diagnostic tests. We combine blood-based biological information related to the tumor, immune response, and host-status with clinical and radiomic data as inputs to our proprietary Diagnostic Cortex® AI platform, which enables us to interpret the holistic disease state of each patient or clinical dataset we encounter.